Skip to Main Content

Paper Details

Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia.
Leuk Lymphoma
0
2023
Author NameAffiliation
Jalpa A DoshiPerelman School of Medicine, University of Pennsylvania
  • 1 - 1

Datasets

Release 1.2